Loading...
 
Back to the list
Mediterr J Rheumatol 2017;28(2):64-9
Article Links
The ASIA syndrome: basic concepts
Abdulla Watad1,2, Kassem Sharif1,2, Yehuda Shoenfeld2
Authors Information

1: Department of Medicine 'B'

2: Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Keywords: ASIA syndrome, autoimmune/inflammatory syndrome induced by adjuvants, adjuvants, vaccine, autoantibodies, silicone, autoimmunity
References
  1. Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011;36:4-8.
  2. Watad A, Quaresma M, Brown S, Cohen Tervaert J W, Rodriguez-Pint I, Cervera R, et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - An update. Lupus 2017:961203316686406.
  3. Gherardi R K, Authier F. Macrophagic myofasciitis: characterization and pathophysiology. Lupus 2012;21:184-9.
  4. Whitehouse M. Oily adjuvants and autoimmunity: now time for reconsideration? Lupus 2012;21:217-22.
  5. Cojocaru M, Chicos B. ASIA or Shoenfeld's syndrome--an autoimmune syndrome induced by adjuvants. Rom J Intern Med 2013;51:131-4.
  6. Shoenfeld Y. Video Q&A: what is ASIA? An interview with Yehuda Shoenfeld. BMC Med 2013;11:118.
  7. Jara L J, Garcia-Collinot G, Medina G, Cruz-Dominguez M D, Vera-Lastra O, Carranza-Muleiro RA, et al. Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld's syndrome). Immunol Res 2016:1-9.
  8. Bomford R. Will adjuvants be needed for vaccines of the future? Dev Biol Stand 1998;92:13-7.
  9. McElrath M J. Selection of potent immunological adjuvants for vaccine construction. Semin Cancer Biol 1995;6:375-85.
  10. Awate S, Babiuk L A, Mutwiri G. Mechanisms of Action of Adjuvants. Front Immunol 2013;4.
  11. Coffman R L, Sher A, Seder R A. Vaccine adjuvants: putting innate immunity to work. Immunity 2010;33:492-503.
  12. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009;18:1217-25.
  13. Edelman R. Vaccine adjuvants. Rev Infect Dis 1980;2:370-83.
  14. Pellegrino P, Clementi E, Radice S. On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives. Autoimmun Rev 2015;14:880-8.
  15. Guimaraes L E, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res 2015;100:190-209.
  16. Ruiz J T, Lujan L, Blank M, Shoenfeld Y. Adjuvants- and vaccines-induced autoimmunity: animal models. Immunol Res 2017;65(1):55-65.
  17. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? J Autoimmun 2000;14:1-10.
  18. Folb P I, Bernatowska E, Chen R, Clemens J, Dodoo A N O, Ellenberg S  S, et al. A Global Perspective on Vaccine Safety and Public Health: The Global Advisory Committee on Vaccine Safety. Am J Public Health 2004;94:1926-31.
  19. Toplak N, Avčin T. Autoantibodies Induced by Vaccine.  Vaccines and Autoimmunity: John Wiley & Sons, Inc 2015;93-102.
  20. Israeli E, Blank M, Shoenfeld Y. Role of Adjuvants in Infection and Autoimmunity.  Vaccines and Autoimmunity: John Wiley & Sons, Inc 2015;9-24.
  21. Petrovsky N, Aguilar J C. Vaccine adjuvants: Current state and future trends. Immunol Cell Biol 2004;82:488-96.
  22. Walls R S. Eosinophil response to alum adjuvants: involvement of T cells in non-antigen-dependent mechanisms. Proc Soc Exp Biol Med (New York, NY) 1977;156:431-5.
  23. Tomljenovic L, Shaw C A. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations. Lupus 2012;21:223-30.
  24. Hanslik T, Vaillant J N, Audrain L, Jubault V, Prinseau J, Baglin A, et al. [Systemic lupus erythematosus and risk of hepatitis B vaccination: from level of evidence to prescription]. Rev Med Interne 2000;21:785-90.
  25. Bagavant H, Nandula S R, Kaplonek P, Rybakowska P D, Deshmukh U S. Alum, an aluminum-based adjuvant, induces Sjogren's syndrome-like disorder in mice. Clin Exp Rheumatol 2014;32:251-5.
  26. Geier D A, Geier M R. A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events. Clin Rheumatol 2015;34:1225-31.
  27. McGarvey P B, Suzek B E, Baraniuk J N, Rao S, Conkright B, Lababidi S, et al. In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases. BMC Immunol 2014;15:61.
  28. Watad A, David P, Brown S, Shoenfeld Y. Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Thyroid Autoimmunity. Front Endocrinol (Lausanne) 2017;7:150.
  29. Soriano A, Verrecchia E, Marinaro A, Giovinale M, Fonnesu C, Landolfi R, et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus 2012;21:153-7.
  30. Cantrell H F, Lombardy E E, Duncanson F P, Katz E, Barone JS. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials. South Med J 2004;97:465-71.
  31. Waisbren B A, Sr. Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns. Med Hypotheses 2008;70:346-8.
  32. Gherardi R K, Authier F J. Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am 2003;23:699-712.
  33. Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA, et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001;124:1821-31.
  34. Guis S, Pellissier J F, Nicoli F, Reviron D, Mattei J P, Gherardi R K, et al. HLA-DRB1*01 and macrophagic myofasciitis. Arthritis Rheum 2002;46:2535-7.
  35. Gulf War illness and the health of Gulf War veterans, scientific findings and recommendations. US Department of Veterans Affairs 2008:50.
  36. Salemi S, D'Amelio R. Could autoimmunity be induced by vaccination? Int Rev Immunol 2010;29:247-69.
  37. Holm B C, Svelander L, Bucht A, Lorentzen J C. The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes. Clin Exp Immunol 2002;127:430-5.
  38. Asa P B, Cao Y, Garry R F. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol 2000;68:55-64.
  39. Barilaro G, Spaziani Testa C, Cacciani A, Donato G, Dimko M, Mariotti A. ASIA syndrome, calcinosis cutis and chronic kidney disease following silicone injections. A case-based review. Immunol Res 2016;64:1142-9.
  40. Baldwin C M, Jr., Kaplan E N. Silicone-induced human adjuvant disease? Ann Plast Surg 1983;10:270-3.
  41. Sun H H, Sachanandani N S, Jordan B, Myckatyn T M. Sarcoidosis of the Breasts following Silicone Implant Placement. Plast Reconstr Surg 2013;131:939e-40e.
  42. Teuber S S, Rowley M J, Yoshida S H, Ansari A A, Gershwin M E. Anti-collagen autoantibodies are found in women with silicone breast implants. J Autoimmun 1993;6:367-77.
  43. Vasey F B, Zarabadi S A, Seleznick M, Ricca L. Where there's smoke there's fire: the silicone breast implant controversy continues to flicker: a new disease that needs to be defined. J Rheumatol 2003;30:2092-4.
  44. Fryzek J P, Signorello L B, Hakelius L, Feltelius N, Ringberg A, Blot W J, et al. Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg 2001;107:206-13.
  45. Maijers M C, de Blok C J, Niessen F B, van der Veldt A A, Ritt M J, Winters H A, et al. Women with silicone breast implants and unexplained systemic symptoms: a descriptive cohort study. Neth J Med 2013;71:534-40.
  46. Colaris M J, van der Hulst R R, Tervaert J W. Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literature. Clin Rheumatol 2017:1-3.
  47. Young V L, Nemecek J R, Schwartz B D, Phelan D L, Schorr M W. HLA typing in women with breast implants. Plast Reconstr Surg 1995;96:1497-519; discussion 520.